7. Ligand Pharmaceuticals Inc. (LGND)
[sc-ad-insert] Expected Yields: N/A
Growth Earnings: 4.0%
Having established a unique niche in the pharmaceuticals industry, this up-and-comer biotechnology company looks poised for big things, with over 125 programs under developmental license with over 72 drug companies, including big names such as Pfizer, Merck, and Amgen.